Roche
BMS signs cancer deal
May 28, 2014Research and Development, Sales and Marketing ASCO, AstraZeneca, BMS, Cancer, Merck, Roche, cytomx, oncology
Bristol-Myers Squibb has partnered with CytomX Therapeutics to discover and develop new immuno-oncology candidates using the latter’s Probody Platform technology. …
Biogen gets CHMP thumbs up
May 27, 2014Sales and Marketing Biogen, CHMP, Gazyvaro (obinutuzumab), Nuwiq, Octapharma, Orphan, Roche, chronic lymphocytic leukaemia, plegridy
Biogen Idec is celebrating after the Committee for Medicinal Products for Human Use (CHMP) gave its multiple sclerosis drug Plegridy …
Authorities visit Roche China offices
May 23, 2014Manufacturing and Production, Medical Communications, Sales and Marketing China, GSK, Roche, Witty, hangzhou, saic
A unit of China’s antitrust regulator has visited Roche’s offices in Hangzhou, according to media reports. The pharma industry has …
Roche gets oncology boost with cancer vaccine
May 16, 2014Research and Development, Sales and Marketing ASCO, Roche, bladder cancer, oncology
Roche’s most advanced experimental cancer immunotherapy has had impressive results in a small Phase I trial, reducing tumour size in …
Giotrif increases lung cancer survival
May 16, 2014Research and Development, Sales and Marketing Boehringer, Iressa, Roche, Tarceva, afatinib, giotrif, lung cancer
Boehringer Ingelheim is trumpeting overall survival results from a new analysis of two late-stage studies involving Giotrif in lung cancer …
EU looks at eye drug allegations
May 8, 2014Sales and Marketing EU, Lucentis, Novartis, Roche, avastin, offlabel
European Union regulators are considering whether they need to take any action over the recent allegations of anti-competitiveness involving Roche …
BMS expands Samsung deal
April 29, 2014Manufacturing and Production BMS, Roche, Samsung, UCSF, biologics, incheon
Bristol-Myers Squibb has expanded its biopharmaceutical manufacturing agreement with South Korea’s Samsung BioLogics. Last year, Bristol-Myers Squibb signed a 10-year …
NICE rejects Kadcyla
April 23, 2014Sales and Marketing CDF, Cancer, Genentech, Kadcyla, NHS, NICE, Roche
NICE has delivered a severe blow to Roche by rejecting its breast cancer ‘smart bomb’ Kadcyla for NHS use in …
Nanobiotix appoints head from Roche


April 22, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, nanobiotix, otin
France-based clinical-stage nanomedicine firm Nanobiotix has hired Thierry Otin as its head of manufacturing and supply. Prior to joining Nanobiotix, …
Roche/Novartis offices raided over anti-competitive activities
April 11, 2014Sales and Marketing Lucentis, Novartis, Roche, SHIP Cluster, avastin, wet AMD
French competition authorities are investigating Roche and Novartis in connection with their marketing of Lucentis for wet age-related macular degeneration …
NICE to look again at Tamiflu after data saga
April 11, 2014Medical Communications, Sales and Marketing Jeremy Hunt, Roche, Tamiflu
The UK government has asked NICE to review its guidance for Roche’s troubled pandemic flu medicine Tamiflu after a new …
Roche joins forces with PatientsLikeMe
April 8, 2014Medical Communications, Research and Development, Sales and Marketing Novartis, PatientsLikeMe, Roche, UCB, real-word data
PatientsLikeMe has set up a five-year agreement with Genentech, Roche’s biologics arm, to allow the firm access to patients’ real-world …
NICE U-turn on Roche cancer drug
April 4, 2014Medical Communications, Sales and Marketing NICE, Roche, Tarceva, U-turn
Roche’s lung cancer drug Tarceva has been given a reprieve to treat relapsed lung cancer patients in the NHS after …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
